Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Repair Windows errors before they cause bigger problems3Fix the driver behind crashes, sound loss and screen glitchesA 2024 WIRED investigation found that four of six telehealth companies tested shipped compounded semaglutide after online intake and varying levels of provider interaction; in that Illinois test, those four did not require proof of BMI or a weight-related condition. That is evidence of a permissive ordering experience at those companies at that time—not proof that every customer did not need treatment, or that the same companies still operate that way. Since then, the FDA has declared the semaglutide injection shortage resolved and tightened the context in which compounded copies may be made.
What did the 2024 investigation actually find?
WIRED journalist Kate Knibbs reported on July 12, 2024, that she tested the online ordering process at six prominent telehealth companies from Illinois. Four shipped vials of compounded semaglutide after online intake and differing levels of provider interaction. In that test, those four companies did not ask for proof of BMI or evidence of a weight-related condition.
The finding is narrower than the headline may suggest. It describes one journalist’s experience with six companies in one state in 2024. It does not establish that a person with no medical need could obtain a prescription from every provider, that the shipped products were appropriate for any particular patient, or that screening was absent in every respect. WIRED also noted that telehealth protocols can vary by state.
So, was it easy in that test? For four of six companies, the process led to a shipment without the specific evidence of BMI or a weight-related condition that the article looked for. Is that a reliable guide to buying online now? No: the investigation was a dated snapshot, and the legal and shortage context has changed.
#1 Best Overall
What does “off-brand Ozempic” mean?
“Off-brand Ozempic” is informal wording, not an FDA-recognized generic category. It can blur together products that have important differences. Compounded semaglutide is not the same thing as an FDA-approved generic, and neither term means counterfeit.
| Product description | What it means | What to verify |
|---|---|---|
| FDA-approved finished drug | A finished product reviewed and approved by FDA. FDA distinguishes these products from compounded drugs. | Confirm the product is the FDA-approved medicine prescribed to you and that it comes through a state-licensed pharmacy. |
| Compounded semaglutide | A drug prepared by a compounding pharmacy under applicable legal conditions. Compounded products are not FDA-approved finished drugs. | Ask which state-licensed pharmacy prepared it, whether the prescription is for you, and how the pharmacy and product can be verified. |
| Counterfeit or illegally marketed product | A product that may be falsely represented or sold outside applicable requirements. FDA says it has encountered counterfeit Ozempic and illegal semaglutide products online. | Do not rely on a seller’s label or claims alone. Use a state-licensed pharmacy and contact a qualified health professional about a product’s legitimacy. |
FDA warns that counterfeit or illegal products may contain the wrong or harmful ingredients, too little or too much active ingredient, or none. The agency has also encountered fraudulent labels on compounded GLP-1 products, including instances where the named pharmacy did not actually compound the product. FDA specifically says semaglutide sodium and semaglutide acetate are different active ingredients from those in approved drugs, and that it lacks information establishing equivalent chemical and pharmacologic properties.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
Why is the 2024 shortage-era context no longer current?
On February 21, 2025, FDA determined that the shortage of semaglutide injection products was resolved. FDA allowed time-limited enforcement discretion after that decision, but its subsequent updates say those periods have ended. The shortage-era conditions discussed in a 2024 article should therefore not be read as current authorization for routine online sales of compounded copies.
Under the current compounding framework, making a compounded product that is essentially a copy of an FDA-approved drug is subject to legal limits and applicable exceptions. For section 503A compounding, the framework includes an individual-patient prescription requirement and restrictions on regularly or in inordinate amounts compounding essentially copied products. An applicable exception can include a documented significant difference for an individual patient. The details depend on the circumstances; a compounded product is not simply a generic version available because a seller labels it “off-brand.”
What has FDA said about online sales and marketing?
On February 6, 2026, FDA said it intended to use enforcement tools against mass-marketed non-FDA-approved compounded GLP-1 products and claims implying those products are the same as approved drugs. On March 3, 2026, FDA said it had warned 30 telehealth companies about illegal marketing, including claims that implied sameness and marketing that obscured product sourcing. These are FDA actions; they do not establish that every company in the 2024 WIRED test received a warning.
FDA’s consumer guidance urges people to buy prescription medicines only from state-licensed pharmacies. A telehealth visit or a polished website does not, by itself, establish that the medicine is FDA-approved, that the named pharmacy actually prepared a compounded product, or that the product is legally marketed.
Rank #4
How can you reduce the risk of an unsafe online purchase?
- Use a real clinical assessment. Discuss your health and treatment options with a qualified prescriber. A streamlined online form is not a substitute for an individualized prescribing decision.
- Check the pharmacy. FDA advises consumers to buy prescription medicines only from state-licensed pharmacies. Verify the pharmacy’s identity and state licensure rather than relying solely on a website’s own claims.
- Ask what product you are being offered. Find out whether it is an FDA-approved finished drug or a compounded product, and ask for the name of the pharmacy that dispenses or compounds it.
- Be wary of sameness claims. FDA has taken action against marketing that implies compounded products are the same as approved drugs or obscures sourcing. A seller’s assurance does not establish approval or equivalence.
- Do not treat a label as proof. FDA has reported fraudulent compounded-product labels, including labels naming a pharmacy that did not compound the product. If the source is unclear, do not inject it; contact a pharmacist or prescriber.
What do the reported adverse events tell consumers?
FDA reported 990 adverse-event reports associated with compounded semaglutide received through May 31, 2026. That is a surveillance count, not 990 confirmed injuries caused by the drug. FDA says a report does not establish causation, and it may not have complete reporting: state-licensed pharmacies that are not outsourcing facilities are not required to submit adverse-event reports.
The number cannot show how common an adverse event is among users, because the count is not a complete census of patients or a confirmed count of drug-caused events. It is a reason to take product sourcing and clinical oversight seriously, not a measure of an individual patient’s odds.
Quick Recap
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
